Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice.
暂无分享,去创建一个
[1] SergiySukhanov,et al. Smooth Muscle Cell–Specific Insulin-Like Growth Factor-1 Overexpression in Apoe−/− Mice Does Not Alter Atherosclerotic Plaque Burden but Increases Features of Plaque Stability , 2010 .
[2] P. Delafontaine,et al. IGF-1, oxidative stress and atheroprotection , 2010, Trends in Endocrinology & Metabolism.
[3] D. Greaves,et al. Inflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applications. , 2010, Clinical science.
[4] P. Delafontaine,et al. Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/- mice but does not reduce atherosclerosis. , 2009, Endocrinology.
[5] K. Ley,et al. Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. , 2009, Trends in immunology.
[6] N. Leitinger,et al. Induction of CCR2-dependent macrophage accumulation by oxidized phospholipids in the air-pouch model of inflammation. , 2009, Arthritis and rheumatism.
[7] G. Brabant,et al. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. , 2009, The Journal of clinical endocrinology and metabolism.
[8] P. Hildebrandt,et al. IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. , 2009, European journal of endocrinology.
[9] D. Seals,et al. Aging is associated with greater nuclear NFκB, reduced IκBα, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans , 2008, Aging cell.
[10] J. Björkegren,et al. Correlation of serum IGF‐I and IGFBP‐1 and ‐3 to cardiovascular risk indicators and early carotid atherosclerosis in healthy middle‐aged men , 2008, Clinical endocrinology.
[11] SergiySukhanov,et al. IGF-1 Reduces Inflammatory Responses, Suppresses Oxidative Stress, and Decreases Atherosclerosis Progression in ApoE-Deficient Mice , 2007 .
[12] N. Rosenthal,et al. Local expression of IGF‐1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] T. Peng,et al. A redox-sensitive pathway mediates oxidized LDL-induced downregulation of insulin-like growth factor-1 receptors⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional figure. Published, JLR Papers in Press, April 1, 2005. DOI 10.1194/jlr.M400478-JLR200 , 2005, Journal of Lipid Research.
[14] P. Delafontaine,et al. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[15] Ying Wang,et al. Stimulatory effect of IGF-I and VEGF on eNOS message, protein expression, eNOS phosphorylation and nitric oxide production in rat glomeruli, and the involvement of PI3-K signaling pathway. , 2004, Nitric oxide : biology and chemistry.
[16] P. Delafontaine,et al. Insulin-Like Growth Factor-1 Receptor Activation Inhibits Oxidized LDL-Induced Cytochrome C Release and Apoptosis via the Phosphatidylinositol 3 Kinase/Akt Signaling Pathway , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[17] H. Kotani,et al. Adiposity Elevates Plasma MCP-1 Levels Leading to the Increased CD11b-positive Monocytes in Mice* , 2003, Journal of Biological Chemistry.
[18] I. Jonsdottir,et al. GH and IGF-I regulate the expression of endothelial nitric oxide synthase (eNOS) in cardiovascular tissues of hypophysectomized female rats. , 2002, European journal of endocrinology.
[19] T. Jørgensen,et al. Heart Disease : A Population-Based Case-Control Study Low Serum Insulin-Like Growth Factor I Is Associated With Increased Risk of Ischemic , 2002 .
[20] G. Churchill,et al. Generation of a New Congenic Mouse Strain to Test the Relationships Among Serum Insulin‐like Growth Factor I, Bone Mineral Density, and Skeletal Morphology In Vivo , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[21] M. Brink,et al. Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. , 2001, Journal of molecular and cellular cardiology.
[22] J. Knowles,et al. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. , 2000, The Journal of clinical investigation.
[23] S. Bennett,et al. Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: inferences from moderate caloric-restricted animals. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.
[24] Lee M. Silver,et al. Mouse Genetics: Concepts and Applications , 1995 .
[25] M. Hammerman,et al. Insulin-like growth factors and aging. , 1987, Endocrinology and metabolism clinics of North America.
[26] E. Baráth,et al. Fundamentals of Biostatistics. , 1992 .